Ventavis CoTherix, Inc. - Treatment for Pulmonary Arterial HypertensionVentavis is an inhaled formulation of iloprost, a prostacyclin analog, indicated for the treatment of pulmonary arterial hypertension (PAH) in patients with NYHA Class III or IV symptoms.
Posted: December 2004
- CoTherix, Inc. Announces Priority Review Designation by the FDA for Ventavis NDA - September 8, 2004
- CoTherix, Inc. Announces Filing of Ventavis NDA - July 1, 2004